Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis

The study was aimed at investigating lipid profile dynamics inpatients with vegetative-dyshormonal cardiopathy (VDC) of various genesis, and assessing the need for lipid-lowering therapy in this coronary heart disease-free group. Lipid levels were measured in 34 participants with VDC, pathological c...

Full description

Bibliographic Details
Main Authors: V. A. Orlov, V. R. Mkrtchyan
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2007-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2045
id doaj-ad034ffe67da46528945a43431dc9c50
record_format Article
spelling doaj-ad034ffe67da46528945a43431dc9c502021-07-28T14:02:09Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202007-02-010165671800Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesisV. A. Orlov0V. R. Mkrtchyan1Российская медицинская академия последипломного образованияРоссийская медицинская академия последипломного образованияThe study was aimed at investigating lipid profile dynamics inpatients with vegetative-dyshormonal cardiopathy (VDC) of various genesis, and assessing the need for lipid-lowering therapy in this coronary heart disease-free group. Lipid levels were measured in 34 participants with VDC, pathological climax and menopause, 30 women with fibromyoma uteri, 32 - with premenstrual syndrome, and 39 - with post-castration syndrome. In all four groups, mean total cholesterol (TCH) level was higher than its Russian norm (5 mmol/l), and mean alpha-CH level was higher than the female norm of 1,2 mmol/l. Calculated on the basis of mean TCH and alpha-CH levels, atherogenicity index was below 3 in all four groups. Mild changes in low-density lipoprotein CH were observed in each group, with the minimal manifestation in premenstrual syndrome participants. Non-pharmaceutical therapy should be administered to all VDC patients; the decision on pharmaceutical treatment should be made individually.https://russjcardiol.elpub.ru/jour/article/view/2045vegetativejdyshormonal cardiopathypathogenesislipid profile dynamicstreatmentwomen
collection DOAJ
language Russian
format Article
sources DOAJ
author V. A. Orlov
V. R. Mkrtchyan
spellingShingle V. A. Orlov
V. R. Mkrtchyan
Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis
Российский кардиологический журнал
vegetativejdyshormonal cardiopathy
pathogenesis
lipid profile dynamics
treatment
women
author_facet V. A. Orlov
V. R. Mkrtchyan
author_sort V. A. Orlov
title Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis
title_short Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis
title_full Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis
title_fullStr Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis
title_full_unstemmed Lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis
title_sort lipid metabolism in patients with vegetative-dyshormonal cardiopathy of various genesis
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2007-02-01
description The study was aimed at investigating lipid profile dynamics inpatients with vegetative-dyshormonal cardiopathy (VDC) of various genesis, and assessing the need for lipid-lowering therapy in this coronary heart disease-free group. Lipid levels were measured in 34 participants with VDC, pathological climax and menopause, 30 women with fibromyoma uteri, 32 - with premenstrual syndrome, and 39 - with post-castration syndrome. In all four groups, mean total cholesterol (TCH) level was higher than its Russian norm (5 mmol/l), and mean alpha-CH level was higher than the female norm of 1,2 mmol/l. Calculated on the basis of mean TCH and alpha-CH levels, atherogenicity index was below 3 in all four groups. Mild changes in low-density lipoprotein CH were observed in each group, with the minimal manifestation in premenstrual syndrome participants. Non-pharmaceutical therapy should be administered to all VDC patients; the decision on pharmaceutical treatment should be made individually.
topic vegetativejdyshormonal cardiopathy
pathogenesis
lipid profile dynamics
treatment
women
url https://russjcardiol.elpub.ru/jour/article/view/2045
work_keys_str_mv AT vaorlov lipidmetabolisminpatientswithvegetativedyshormonalcardiopathyofvariousgenesis
AT vrmkrtchyan lipidmetabolisminpatientswithvegetativedyshormonalcardiopathyofvariousgenesis
_version_ 1721269688403492864